A Hybrid Phase I ‐II/III Clinical Trial Design Allowing Dose Re‐Optimization in Phase III

Biometrics,Volume 0, Issue ja, -Not available-.

Source: Biometrics - October 27, 2018 Category: Biotechnology Authors: Andrew G. Chapple, Peter F. Thall Source Type: research